Presently, SP receptor NK-1R antagonist (Aprepitant) has been utilized in the treatment of chemotherapy-induced nausea and vomiting [15], and could be used to relieve cough in lung cancer [29]. The gene discussed is TACR1; the disease is lung cancer.